Skip to main content
Caplight Logo









Eysz

Eysz

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://eyszlab.com/

Last Round

Grant

Oct 3, 2025

Total Funding Raised

$3.77M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Eysz is a digital health company that has developed a platform for the diagnosis and management of neurological and psychiatric conditions using AI-driven analysis of biometric data.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Computer Vision, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

digital biomarkersseizure detectioneye movement analysiseye trackingepilepsy diagnosisclinical decision supportSoftware as a Medical DeviceSaMDmedical AIchildhood absence epilepsyneurological disorderscomputer visionremote patient monitoringdigital healthclinical trial softwareoculometricsfacial biometrics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eysz Comparables

Compare Eysz with similar companies based on industry and business-model similarity.

Eysz comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
neuroClues
78%
Neurotrack Technologies, Inc.
69%
Neuronostics
66%

Eysz Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 3, 2025
Pre SeedNov 1, 2022
CrowdfundingJun 15, 2021
GrantMay 15, 2021
GrantSep 30, 2020
Accelerator
Aug 1, 2019

Key People

Founding team and executive leadership

Parth Amin

Co-Founder And COO

Founding Team

Rachel Kuperman

CEO

Executive Team

Eysz Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 601% MoM, from 194 to 1.4K.

  • Jan 5, 2026

    Monthly visitors grew 126% MoM, from 194 to 439.

Eysz Filings

Explore SEC and related filing metadata, where available.

Eysz filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eysz's valuation, stock price, and market status.

Is Eysz a public or private company?

Eysz is a private company.

What is the current stock price of Eysz?

Eysz is a private company with no public stock price. No recent secondary market data is available.

How much is Eysz worth (valuation)?

Valuation information for Eysz is not publicly available.

Can I buy Eysz stock?

Eysz shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Eysz's last funding round?

Eysz's most recent funding round was Grant on October 3, 2025.

Who are the main investors in Eysz?

Key investors in Eysz include HealthTech Capital, Plug and Play Tech Center, NIH RADx, National Institute of Nursing Research, Epilepsy Foundation.

Will Eysz IPO soon?

No public IPO plans have been announced for Eysz.

How can I track Eysz secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eysz's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerkeley, California
Employee Range4
Year Founded2018
Last FundingOct 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?